Clinical Trial Update: Risperdal Consta and Health Care Utilization in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating health care utilization in patients with schizophrenia treated with Risperdal Consta (risperidone long-acting injectable).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Risperdal Consta (risperidone long-acting injectable)

Snippet

Sponsor: Emory University | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED